ADVERSE REACTIONS--------------------------
VUITY (pilocarpine hydrochloride ophthalmic solution) is provided as a 1.25% solution (12.5 mg/mL). 4 CONTRAINDICATIONS VUITY is contraindicated in patients with known hypersensitivity to the active ingredient or to any of the excipients.
Download ADVERSE REACTIONS--------------------------
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION • …
www.rxabbvie.comPrior to initiating DUOPA, convert patients from all other forms of levodopa to oral immediate-release carbidopa-levodopa tablets (1:4 ratio). Patients should remain on a stable dose of their
DOSAGE AND ADMINISTRATION WARNINGS AND …
www.rxabbvie.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE CREON® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.
HIGHLIGHTS OF PRESCRIBING INFORMATION 1.In …
www.rxabbvie.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MAVYRET safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
www.rxabbvie.comFULL PRESCRIBING INFORMATION WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including SYNTHROID, either alone or …
MEDICATION GUIDE - RxAbbVie
www.rxabbvie.comMEDICATION GUIDE HUMIRA® (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before you start taking it …
MEDICATION GUIDE - RxAbbVie
www.rxabbvie.comMEDICATION GUIDE HUMIRA® (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before …
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.rxabbvie.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TECHNIVIE safely and effectively. See full …
VENCLEXTA (venetoclax tablets) for oral use or after ...
www.rxabbvie.comPatients should continue VENCLEXTA 400 mg once daily for 24 months from Cycle 1 Day 1 of rituximab. VENCLEXTA as Monotherapy The recommended dose of VENCLEXTA is 400 mg once daily after the patient has completed
LUPRON DEPOT 3.75 mg (leuprolide acetate for …
www.rxabbvie.comLUPRON DEPOT® 3.75 mg (leuprolide acetate for depot suspension) Rx only DESCRIPTION Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin-
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.rxabbvie.comFULL PRESCRIBING INFORMATION WARNING: SECONDARY EXPOSURE TO TESTOSTERONE • Virilization has been reported in children who were secondarily exposed to testosterone gel [see Warnings and Precautions (5.2) and Adverse Reactions (6.2)]. • Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel [see Dosage and Administration (2.2) and Warnings …
Related documents
Oral Rehydration Solutions: Made at Home
rehydrate.orgMix an oral rehydration solution using one of the following recipes; depending on ingredients and container availability: Ingredients: Half (1/2) level teaspoon of Salt Six (6) level teaspoons of Sugar One (1) Litre of clean drinking or boiled water and then cooled 5 cupfuls (each cup about 200 ml.) Preparation Method:
Symptom Management Summary Oral Care - Alberta Health …
www.albertahealthservices.caAkabutu’s mouthwash has to be compounded by pharmacies and contains: Nystatin 100,000 unit/ml 42 ml, Lidocaine HCL Viscous 2% 50 ml, Sodium chloride 0.9% 200 ml, Hydrocortisone 10 mg x 5 tabs, glycerin 100% 4 ml. Swish/gargle 15 -30 ml in mouth/throat x 1 minute (spit out excess), q4-6h prn.
5 mg/5 ml oral solution sodium picosulfate
www.medicines.org.uk5 mg/5 ml oral solution sodium picosulfate Additional Requirements of Packaging Site PITCH CODE Technical colors Diecut-Legendcase Free area Glue points ... before, start with one 5 ml spoonful and increase to two if necessary. When your bowel regularity has returned to normal, the dose can usually be stopped.
HIGHLIGHTS OF PRESCRIBING INFORMATION ——— …
www.novo-pi.comminimize the risk of hypoglycemia [see Warnings and Precautions (5.2)]. 3 DOSAGE FORMS AND STRENGTHS Injection: TRESIBA ® is available as a clear and colorless solution: • 100 units/mL (U-100): 3 mL single-patient-use FlexTouch® disposable prefilled pen • 100 units/mL (U-100): 10 mL multiple-dose vial